Serina Therapeutics (SER) Retained Earnings (2017 - 2025)
Serina Therapeutics (SER) has disclosed Retained Earnings for 9 consecutive years, with -$14000.0 as the latest value for Q4 2025.
- Quarterly Retained Earnings changed N/A to -$14000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$14000.0 for FY2025, N/A changed from the prior year.
- Retained Earnings hit -$14000.0 in Q4 2025 for Serina Therapeutics, up from -$60.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$14000.0 in Q4 2025 to a low of -$127.6 million in Q3 2023.
- Historically, Retained Earnings has averaged -$82.1 million across 5 years, with a median of -$101.6 million in 2021.
- Biggest five-year swings in Retained Earnings: tumbled 225465.91% in 2021 and later skyrocketed 71.45% in 2023.
- Year by year, Retained Earnings stood at -$105.7 million in 2021, then fell by 9.89% to -$116.2 million in 2022, then soared by 71.45% to -$33.2 million in 2023, then fell by 25.32% to -$41.6 million in 2024, then soared by 99.97% to -$14000.0 in 2025.
- Business Quant data shows Retained Earnings for SER at -$14000.0 in Q4 2025, -$60.2 million in Q3 2025, and -$55.6 million in Q2 2025.